$ALLE

Allegion plc (ALLE) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Exhibit 99.1 NEWS RELEASE Allegion Announces Tim Eckersley’s Retirement, Names Serge Zappone Leader of Allegion International DUBLIN (Sept. 8, 2026) – Allegion plc (NYSE: ALLE), a leading global security products and solutions provider, today announced the appointment of Serge Za

Powell (POWL) reported Q2 revenue of $311.7M, up 8.9% YoY, missing estimates. Sanmina (SANM) reported $3.46B revenue, up 69.7% YoY, beating estimates. Allegion (ALLE) reported $1.15B revenue, up 12.7% YoY, surpassing estimates. POWL stock is down 17%, SANM down 6.4%, ALLE up 12.3% since earnings.

MIZELL STEVEN purchased 170 shares of Allegion plc (ALLE) at $158.28 on 2026-08-28.

Analysts covering Allegion (ALLE) have a 'Moderate Buy' consensus, with a mean price target of $171.33, implying a 5.3% upside. JPMorgan maintained a 'Hold' rating and a $170 target, suggesting a 4.5% upside. The most bullish target is $190, indicating a 16.8% potential gain.

Wenos Vincent (SVP - Chief Technology Officer) sold 1,000 shares of Allegion plc (ALLE) at $168.25 ($0.17M total) on 2026-08-06.

Eckersley Timothy P (President-Intl & SVP-Allegion) sold 6,417 shares of Allegion plc (ALLE) at $157.26 ($1.01M total) on 2026-07-27.

Allegion (NYSE: ALLE) raised its 2026 outlook after Q2 results. The company cited strong Americas demand, especially nonresidential markets, and electronics adoption. It increased full-year organic revenue growth to 3.5% to 4.5% and adjusted EPS to $8.85 to $9.00. Q2 revenue was about $1.2B (+12.7% YoY) with organic revenue up 6.9%, while Europe demand stayed soft.

Allegion (NYSE: ALLE) shares rose 12.7% after the company reported Q2 results that beat analysts and raised full-year guidance. Revenue was $1.15B, above $1.12B expected. Adjusted EPS was $2.40 vs $2.22 consensus. Full-year adjusted EPS guidance was raised to $8.93 (midpoint).

Investing.com reports U.S. trending stocks with large daily moves. NovoCure (NVCR) rose 23.4% to $19.33 after JPMorgan resumed coverage. WEX (WEX) gained 9.6% after a Q2 EPS beat ($5.35 vs $5.06) and raised guidance. Alphabet fell about 7% on a higher AI spending outlook.

Allegion shares rose about 12.2% in pre-open after the company reported Q2 2026 adjusted EPS of $2.40 versus about $2.21 expected, and revenue of $1.15 billion versus $1.12 billion expected. Allegion also raised full-year 2026 adjusted EPS guidance midpoint to about $8.93. Adjusted EBITDA was $296.7 million versus $274.9 million estimates.